NLM Digital Collections

Search

Start Over Authors Pearson, Steven D., author ✖Remove constraint Authors: Pearson, Steven D., author Publication Year 2000 to 2024 ✖Remove constraint Publication Year: <span class="from" data-blrl-begin="2000">2000</span> to <span class="to" data-blrl-end="2024">2024</span>

32. Aducanumab for Alzheimer’s disease: effectiveness and value

Author(s):
Lin, Grace A., author
Whittington, Melanie D., author
Synnott, Patricia G., author
McKenna, Avery, author
Campbell, Jon, author
Pearson, Steven D., author
Rind, David M., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, August 5, 2021
Subject(s):
Alzheimer Disease -- drug therapy
Antibodies, Monoclonal
United States

33. Targeted immune modulators for ulcerative colitis: effectiveness and value : final evidence report and meeting summary

Author(s):
Ollendorf, Daniel A., author
Bloudek, Lisa, author
Carlson, Josh J., author
Pandey, Rajshree, author
Fazioli, Katherine, author
Chapman, Rick M., author
Bradt, Pamela, author
Pearson, Steven D., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, October 16, 2020
Subject(s):
Colitis, Ulcerative -- drug therapy
Immune System -- drug effects
United States

34. Strengthening the accelerated approval pathway: an analysis of potential policy reforms and their impact on uncertainty, access, innovation, and costs

Author(s):
Kaltenboeck, Anna, author
Mehlman, Amanda, author
Pearson, Steven D., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, April 26, 2021
Subject(s):
Drug Approval -- economics
Drug Approval -- legislation & jurisprudence
United States

35. Crizanlizumab, voxelotor, and L-glutamine for sickle cell disease: effectiveness and value

Author(s):
Bradt, Pamela, author
Synnott, Patricia G., author
Chapman, Rick, author
Beinfeld, Molly, author
Rind, David M., author
Pearson, Steven D., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 12, 2020
Subject(s):
Anemia, Sickle Cell -- drug therapy
Antibodies, Monoclonal -- therapeutic use
Glutamine -- therapeutic use
Hemoglobin, Sickle -- antagonists & inhibitors
United States

37. Belimumab and voclosporin for lupus nephritis: effectiveness and value : final report

Author(s):
Tice, Jeffrey A., author
Agboola, Foluso, author
Herron-Smith, Serina, author
Chapman, Rick, (Of Institute for Clinical and Economic Review), author
Pearson, Steven D., author
Mandrik, Olena, author
Thokala, P. (Praveen), author
Fotheringham, James, (Of University of Sheffield), author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, April 16, 2021
Subject(s):
Antibodies, Monoclonal, Humanized
B-Cell Activating Factor -- antagonists & inhibitors
Calcineurin Inhibitors -- therapeutic use
Cyclosporine -- therapeutic use
Immunosuppressive Agents -- therapeutic use
Lupus Nephritis -- drug therapy
Treatment Outcome
United States

38. Treatments for anemia in chronic kidney disease: effectiveness and value : final evidence report

Author(s):
Mustafa, Reem A., author
Fox, Grace, (Of Institute for Clinical and Economic Review), author
Campbell, Jonathan D., author
Agboola, Foluso, author
Pearson, Steven D., author
Rind, David M., author
Bloudek, Lisa, author
Carlson, Josh J., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 5, 2021
Subject(s):
Glycine -- analogs & derivatives
Hematinics -- therapeutic use
Isoquinolines -- therapeutic use
Hypoxia-Inducible Factor-Proline Dioxygenases -- antagonists & inhibitors
Anemia, Iron-Deficiency -- drug therapy
Renal Insufficiency, Chronic -- complications
Renal Insufficiency, Chronic -- drug therapy
Treatment Outcome
United States

39. Gene therapies for sickle cell disease: final evidence report

Author(s):
Beaudoin, Francesca, author
Nikitin, Dmitriy, author
Campbell, Jonathan D., author
McKenna, Avery, author
Pearson, Steven D., author
Rind, David M., author
Thokala, P. (Praveen), author
Spackman, David Eldon, author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, August 21, 2023
Subject(s):
Anemia, Sickle Cell -- therapy
Genetic Therapy
United States

40. Resmetirom and obeticholic acid for non-alcoholic steatohepatitis (NASH): final evidence report

Author(s):
Tice, Jeffrey A., author
Fahim, Shahariar Mohammed, author
Richardson, Marina, author
Herce-Hagiwara, Belen, author
Chu, Janet N., author
Pearson, Steven D., author
Rind, David M., author
Suh, Kangho, author
Carlson, Josh, author
Dickerson, Ronald, author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, May 25, 2023
Subject(s):
Chenodeoxycholic Acid -- analogs & derivatives
Liver Cirrhosis -- drug therapy
Non-alcoholic Fatty Liver Disease -- drug therapy
Pyridazines
Uracil -- analogs & derivatives
United States